The Deep Genome Project
暂无分享,去创建一个
Steve D. M. Brown | Jacqueline K. White | F. Mammano | J. Lupski | A. Beaudet | R. Braun | M. Dickinson | A. Flenniken | Xiang Gao | Y. Hérault | K. C. K. Lloyd | A. Mallon | C. McKerlie | T. Meehan | S. Murray | H. Parkinson | D. Smedley | S. Wells | M. Caulfield | D. Valle | R. Mcinnes | P. Flicek | M. H. Angelis | G. Tocchini-Valentini | W. Wurst | D. Adams | D. Valle | K. Boycott | K. Lloyd | M. D. de Angelis | G. Baynam | Y. Obata | J. Seong | L. Nutter | S. Lyonnet | S. Galande | F. Bosch | C. Macrae | M. Pepper | J. Heaney | Steve D. M. Brown | R. Sedláček | T. Shiroishi | S. Wells | A. Grobler | M. Dobbie | K. Lloyd | Helen Parkinson | R. Cohn | C. Wang | Ying Xu | J. Seong | R. Cohn | Rod Mcinnes | G. Tocchini-Valentini | Mark J. Caulfield | Fatima Bosch | Y. Obata | Chi-Kuang Leo Wang | Jacqueline K. White | Ying Xu | W. Wurst | Paul Flicek
[1] J. Rosenfeld,et al. Reanalysis of Clinical Exome Sequencing Data. , 2019, The New England journal of medicine.
[2] Steve A. Murray,et al. New models for human disease from the International Mouse Phenotyping Consortium , 2019, Mammalian Genome.
[3] D. Powell,et al. Predicting human disease mutations and identifying drug targets from mouse gene knockout phenotyping campaigns , 2019, Disease Models & Mechanisms.
[4] M. Gerstein,et al. Insights into genetics, human biology and disease gleaned from family based genomic studies , 2019, Genetics in Medicine.
[5] J. Lupski,et al. TBX6 compound inheritance leads to congenital vertebral malformations in humans and mice , 2018, Human molecular genetics.
[6] K. Boycott,et al. The unsolved rare genetic disease atlas? An analysis of the unexplained phenotypic descriptions in OMIM® , 2018, American journal of medical genetics. Part C, Seminars in medical genetics.
[7] Luís A. Nunes Amaral,et al. Large-scale investigation of the reasons why potentially important genes are ignored , 2018, PLoS biology.
[8] Anton Simeonov,et al. Unexplored therapeutic opportunities in the human genome , 2018, Nature Reviews Drug Discovery.
[9] Anton Simeonov,et al. Unexplored therapeutic opportunities in the human genome , 2018, Nature Reviews Drug Discovery.
[10] Lily Hoffman-Andrews. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice , 2017, Journal of law and the biosciences.
[11] Mary Beth Nebel,et al. Altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice , 2017, Nature Neuroscience.
[12] Steve D. M. Brown,et al. Disease Model Discovery from 3,328 Gene Knockouts by The International Mouse Phenotyping Consortium , 2017, Nature Genetics.
[13] R. Guigó,et al. Comparative transcriptomics in human and mouse , 2017, Nature Reviews Genetics.
[14] C. Yau,et al. The Influence of the Microbiome on Type 1 Diabetes , 2017, The Journal of Immunology.
[15] Donna M. Muzny,et al. Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation , 2017, The New England journal of medicine.
[16] Tudor Groza,et al. The Monarch Initiative: an integrative data and analytic platform connecting phenotypes to genotypes across species , 2016, bioRxiv.
[17] R. M. Owen,et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.
[18] J. Lupski,et al. TBX6 null variants and a common hypomorphic allele in congenital scoliosis. , 2015, The New England journal of medicine.
[19] Shane J. Neph,et al. A comparative encyclopedia of DNA elements in the mouse genome , 2014, Nature.
[20] Steve D. M. Brown,et al. The International Mouse Phenotyping Consortium: past and future perspectives on mouse phenotyping , 2012, Mammalian Genome.
[21] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[22] Colin N. Dewey,et al. Initial sequencing and comparative analysis of the mouse genome. , 2002 .